Children in the world's poorest countries to get free insulin
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Roche signs definitive agreement to acquire Memory Pharmaceuticals
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Pfizer's Novel HIV/AIDS Treatment SELZENTRY™
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Sandoz receives positive EU opinion for biosimilar filgrastim
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
- Details
- Category: Financial
Johnson & Johnson (NYSE: JNJ) and Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI), a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, have announced a definitive agreement whereby Omrix will be acquired for approximately $438 million in a cash tender offer.
GSK and Neptunus form joint venture for the co-development of flu vaccines
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
More Pharma News ...
- AstraZeneca to divest Nordic over-the-counter portfolio
- Pfizer withdraws its application to change the marketing authorisation for Viagra
- AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation
- Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of All Infants
- Pfizer Launches Global Regenerative Medicine Research Unit
- SEROQUEL XR and SEROQUEL Approved in Europe for New Indications
- Tarceva brings new hope to patients with advanced non-small cell lung cancer